Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

Oct. 25, 2021, 8:53 a.m. EDT

Moderna says its COVID-19 shot generates 'robust' response in children 6 to 11

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Moderna Inc. (MRNA)
  • X
    BioNTech SE ADR (BNTX)
  • X
    Pfizer Inc. (PFE)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA -4.33% gained 0.9% in premarket trading on Monday after the company shared interim data from a Phase 2/3 clinical study evaluating its COVID-19 vaccine in children between the ages of 6 and 11 years old. The trial, which has 4,753 participants between the ages of 6 and 11, evaluated the immune response one month after the second dose. Moderna said the vaccine met the trial's endpoint and generated a "robust neutralizing antibody response" but it did not provide an efficacy rate in the news release. The company also said it plans to submit the clinical data to the FDA in the "near term." The news was announced one day before a Food and Drug Administration advisory committee is set to discuss the benefits and risks of BioNTech SE /zigman2/quotes/214419716/composite BNTX -2.81% and Pfizer Inc.'s /zigman2/quotes/202877789/composite PFE -2.41% COVID-19 vaccine in children between the ages of 5 and 11. The Moderna and BioNTech/Pfizer COVID-19 vaccines both require two shots and use mRNA technology. Moderna's stock has soared 212.5% so far this year, while the broader S&P 500 /zigman2/quotes/210599714/realtime SPX +1.56% is up 21.0%.

/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 297.15
-13.46 -4.33%
Volume: 9.88M
Dec. 2, 2021 12:16p
P/E Ratio
18.23
Dividend Yield
N/A
Market Cap
$125.94 billion
Rev. per Employee
$617,996
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 325.09
-9.39 -2.81%
Volume: 2.53M
Dec. 2, 2021 12:15p
P/E Ratio
9.40
Dividend Yield
N/A
Market Cap
$81.12 billion
Rev. per Employee
$283,276
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 53.36
-1.32 -2.41%
Volume: 18.34M
Dec. 2, 2021 12:16p
P/E Ratio
15.90
Dividend Yield
2.91%
Market Cap
$306.91 billion
Rev. per Employee
$533,860
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,583.53
+70.49 +1.56%
Volume: 1.21B
Dec. 2, 2021 12:16p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.